Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.18down ₹0.02 (0.20%)BSE ₹10.17
Share price at the NSE close on 2 Nov 2026. Previous close ₹10.20.
2 Nov: open ₹10.40, high ₹10.70, low ₹10.06
52-week range of traded prices to 2 Nov 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 2 Nov 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹198 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 98,61771.1% delivered
Nectar Lifesciences dividends
21 filed, newest first.
Jul 2020
May 2019
May 2018
Jun 2017
May 2017
May 2016
Oct 2015
May 2015
May 2014
Sep 2013
30 Sep · Dividend
Members in their Annual General Meeting held on September 30, 2013 have declared the Final Dividend of Re. 0.10/- per equity share ( 10% on the face value of Re. 1/- per equity share) for the financial year 2012-13. The Dividend will be paid latest by October 29, 2013.
May 2013
15 May · Dividend
Board of Directors in their meeting held on May 15, 2013 have recommended 10% Final Dividend i.e. Re 0.10/- per equity share to the members of the company, out of profits of the company for the financial year 2012-13, subject to the approval of the members in their Annual General meeting.
Oct 2012
1 Oct · Dividend
Members in their Annual General Meeting held on September 29, 2012 have declared the Final Dividend of Re.0.10/- per equity share (10% on the face value of Re.1/- per equity share) for the financial year 2011-12. The Dividend will be paid latest by October 28, 2012.
Aug 2012
10 Aug · Dividend
Board of Directors of the Company at its meeting held on August 09, 2012, inter alia decided and approved the recommendation of 10% Final Dividend i.e. Re 0.10/- per equity share to the members of the company, out of profits of the Company for the Financial year 2011-12.
Sep 2011
30 Sep · Dividend
Members in their Annual General Meeting held on September 30, 2011 have declared the Final Dividend of Re.0.10/- per equity share (10% on the face value of Re.1/- per equity share) for the financial year 2010-11. The Dividend will be paid latest by October 29, 2011.
Aug 2011
12 Aug · Dividend
Board of Directors in their meeting held on August 12, 2011 have inter alia decided and approved : (1) The recommendation of 10% Final Dividend i.e, Re. 0.10/- per equity share to the members of the Company, out of profits of the Company for the Financial year 2010-11.
Jan 2010
15 Jan · Dividend
Board of Directors in their meeting held on today i.e. January 15, 2010 have declared the interim dividend of Re. 0.25/- per equity share (25% on the face value of Re. 1/- per equity share) out of profits of the Company for the financial year 2009-10. Futher the dividend will be payable latest by February 14, 2010.
Sep 2009
22 Sep · Dividend
Members in their Annual General Meeting held on September 22, 2009 have declared the final dividend of Re. 0.10/- per equity share (10% on the face value of Re. 1/- per equity share) for the financial year 2008-09. The dividend will be paid latest by October 21, 2009.
Jun 2009
30 Jun · Dividend
Board of Directors, at their meeting held on June 30, 2009 has recommended the Final Dividend of Re. 0.10 per equity share (10% on the face value of Re.1/- per equity share) to the Members of the Company, out of profits of the Company for the financial year 2008-09.
Sep 2008
29 Sep · Dividend
Members in their Annual General Meeting held on September 29, 2008 have declared the final dividend of Rs.4/- per equity share (40 % on the face value of Rs. 10/- per equity share) for the financial year 2007-08. The dividend will be paid latest by October 28, 2008.
Jun 2008
20 Jun · Dividend
Board of Directors of the Company at its meeting held on June 20, 2008 has decided and approved the recommendation of 40% Final Dividend i.e. Rs.4/- per equity share to the Members of the Company, out of profits of the Company for the financial year 2007-08.
Apr 2007
28 Apr · Dividend
The Audit Committee in its Meeting held on 27.04.2007 has recommended to the Board of Directors a Final Dividend @ 20% to the Members, which the Board has accepted to consider at the time of adoption of audited financial statements for the year ended 31.03.2007